Try our Advanced Search for more refined results
August 06, 2012
Pfizer Inc. v. Teva Pharmaceuticals USA
Case Number:
12-1576
Court:
Nature of Suit:
830 Patent Infringement (Fed. Question)
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
February 06, 2014
Fed. Circ. OKs Ruling Barring Generic Lyrica Until 2018
Pfizer Inc. on Thursday won a ruling from the Federal Circuit upholding a lower court's decision blocking a slew of generic-drug makers, including Teva Pharmaceuticals USA Inc. and Actavis Inc., from selling generic versions of its popular nerve pain drug Lyrica until the patent for the drug expires in 2018.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login